, Pentadecapeptide BPC 157 and the central nervous system, Medknow, 2022
Since 2001, many clinical trials have been conducted on omnivores to see if lowering homocysteine through pharmacological doses of folate, B12, and sometimes vitamin B6, could reduce the risk of cardiovascular disease, premature death, and cognitive decline
Researchers have shown interest in these compounds for areas including: Cellular signaling Metabolic pathways Recovery and tissue biology Mitochondrial function Inflammatory pathways Exercise physiology The advisory committees recommendation reflects growing debate about how these substances should be regulated
Research Chemicals ARE NOT FOR HUMAN CONSUMPTION What is AOD-9604
Transient nausea: occasionally reported, typically mild and associated with higher doses